GSK Investigational Site

Bryan, Texas 77802

0 studies enrolling now · 10 studies all time

What they study most

Acellular Pertussis, Atherosclerosis, Diabetes Mellitus, Type 2, Diphtheria, Dyslipidaemias, Infections, Meningococcal, Infections, Rotavirus, Measles, Mumps, Rubella, Tetanus, Thrombocytopaenia

Studies at this site

• Safety and Immunogenicity of GSK Meningococcal Group B Vaccine and 13-valent Pneumococcal Vaccine Administered Concomitantly With Routine Infant Vaccines to Healthy Infants — Completed
• Immunogenicity and Safety of GlaxoSmithKline Biologicals' MMRV Vaccine vs. ProQuad® in Children 12-14 Months of Age — Completed
• A Study In Patients With Type 2 Diabetes Mellitus — Completed
• A Study To Evaluate The Safety And Efficacy Of An Investigational Diabetes Drug In Poorly Controlled Type II Diabetics — Completed
• Efficacy and Safety Study of Rosiglitazone/Metformin Therapy vs Rosiglitazone and Metformin in Type 2 Diabetes Subjects — Completed
• SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adult Cancer Patients Receiving Chemotherapy — Completed
• Study of 2 Doses of HRV Vaccine Given Concomitantly or Separately With Routine Vaccinations in Healthy Infants in USA — Completed
• A Combined Tdap Vaccine Used As A Booster Compared To Licensed Td Vaccine — Completed
• SB-480848 In Subjects With Coronary Heart Disease — Completed
• Dyslipidemia Study Investigating The Increase In "Good Cholesterol" — Completed